Lulu Xu
Principal·New Enterprise Associates
Lulu Xu is a Principal on NEA's Healthcare team, focused on later-stage life sciences investments. Before joining NEA in 2021, she worked at AbbVie across R&D, M&A, and Enterprise Strategy, including acquisition and integration of strategic companies and assets. Her NEA bio lists companies including Xaira Therapeutics, Zenas BioPharma, Abcuro, Brenig, and National Resilience.
See the rest of Lulu Xu's profile.
Deal history, investment focus, outreach angles and the rest of the background. One email, no password — we send a link and you land right back here.